Advertisements

Nurofen Children

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Nurofen Children

Property Description
Active ingredient Ibuprofen
Form Oral suspension (Liquid)
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common use General pain relief and fever reduction
Origin Synthetic, Propionic acid derivative

What Type of Medicine is Nurofen Children?

Nurofen Children is a branded paediatric preparation whose single active ingredient is Ibuprofen. This compound is chemically synthesized as a Propionic acid derivative and is classified within the pharmacological group known as Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Ibuprofen's function is broadly clinically recognized, meaning it has the capability to reduce inflammation, pain, and fever. Its NSAID classification is a key differentiating feature, as it means it possesses an anti-inflammatory property in addition to its primary analgesic and antipyretic effects, distinguishing it from non-NSAID fever-reducers.


Composition and Form: The Oral Suspension

The medicine is specifically provided as an Oral suspension, which is a palatable liquid formulation where the active substance, Ibuprofen, is finely distributed within an aqueous vehicle. This specific liquid format is a key feature for the paediatric population, as the oral suspension facilitates ease of administration and dosage adjustment for infants and young children who may be unable to swallow solid tablets. The preparation is designed to be administered via the oral route of administration and typically includes flavoring agents to enhance palatability.


General Purpose: Analgesic and Antipyretic Action

The fundamental purpose of this medicine is to provide symptomatic relief by leveraging Ibuprofen's combined action. The benefit is achieved by temporarily interfering with the body's processes, specifically the inhibition of prostaglandin synthesis. Prostaglandins are chemical messengers that drive discomfort, and blocking their production delivers the medicine's dual benefit, making the preparation widely used to temporarily reduce fever (antipyretic effect) and alleviate general pain (analgesic effect).

Advertisements

What side effects are possible with Nurofen Children?

Possible Side Effects and Safety Information

The safety profile of Ibuprofen oral suspension, as documented in official regulatory sources, organizes possible adverse reactions by frequency and affected organ system.

Adverse Reaction Classification

Side effects are classified by their documented frequency, typically including Common (e.g., dyspepsia, abdominal pain), Uncommon (e.g., headache, dizziness, various skin rashes), and Rare reactions (e.g., blood and liver disorders).

System-Organ Class (SOC) Examples of Officially Listed Adverse Reactions
Gastrointestinal Disorders Dyspepsia, nausea, vomiting, and, rarely, gastrointestinal bleeding or ulceration.
Nervous System Disorders Headache, dizziness, and, very rarely, aseptic meningitis.
Immune System Disorders Hypersensitivity reactions, including rare cases of severe anaphylaxis.

Serious Safety Considerations

Official labeling highlights the risk of serious adverse reactions, which, though rare, are clinically significant. These include potentially fatal Gastrointestinal Bleeding and Perforation, the risk of serious Cardiovascular Thrombotic Events (e.g., stroke), and Severe Cutaneous Reactions (e.g., Stevens-Johnson Syndrome). The risk of these serious events is formally noted to be associated with higher doses and long-term exposure.

Safety-Related Restrictions

Ibuprofen oral suspension should not be used in individuals with active gastrointestinal bleeding or peptic ulceration, severe heart, renal, or hepatic failure, or a history of allergic reactions to aspirin or other NSAIDs. Older adults are explicitly noted in regulatory documents to be at a greater risk of serious gastrointestinal consequences.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Property Official Regulatory Documentation
Documented overdose presentations Primarily involve gastrointestinal signs (nausea, vomiting, abdominal pain) and CNS symptoms (drowsiness, dizziness, confusion, severe headache, convulsions, coma) [Source 1.1].
Physiological systems affected Gastrointestinal tract, Central Nervous System (CNS), Renal system (acute renal failure), Metabolic system (metabolic acidosis), and Cardiovascular system (hypotension, shock) [Source 1.1], [Source 3.3].
Population-specific overdose notes Risk of renal impairment in dehydrated children and adolescents is noted [Source 3.1]. Infants and children administered oral ibuprofen have been reported to develop CNS depression, seizures, and transient renal failure [Source 3.4].
Emergency-response statements Seek professional assistance or contact a Poison Control Center immediately [Source 1.3], [Source 2.5]. Treatment is symptomatic and supportive [Source 1.1].

Official Overdose Statements

  • The most common officially documented manifestations of overdose include nausea, vomiting, abdominal pain, drowsiness, and confusion [Source 1.1].
  • Severe outcomes documented in official sources include gastrointestinal bleeding and perforation, acute renal failure, and CNS depression leading to coma or convulsions [Source 1.4], [Source 2.7].
  • Immediate medical assistance must be sought or a Poison Control Center contacted right away when an overdose is suspected [Source 1.3].
  • Management for overdose is officially defined as symptomatic and supportive, and may include procedures such as administering activated charcoal and monitoring vital signs [Source 2.3].
  • Dehydrated children and adolescents are explicitly noted in regulatory documents as a population at risk for renal impairment following overdose [Source 3.1].

Connection to the Overall Overdose Profile

Government regulatory documents define the overdose profile by listing the explicit clinical manifestations that may present, from common gastrointestinal effects to severe outcomes like organ failure. The profile strictly mandates that an individual must seek immediate medical attention for a suspected overdose, establishing that the official required action is to contact professional medical assistance. This mandatory help-seeking instruction is crucial because regulatory information confirms there is no specific antidote, necessitating specialized supportive care and monitoring procedures.

Advertisements

Therapeutic Uses of Nurofen Children

Nurofen Children may be relevant across three main therapeutic domains of use, and is applied for supportive symptomatic assistance. It is relevant in contexts involving heightened systemic burden, such as conditions where symptoms may intensify temporarily including elevated body temperature (fever), and symptoms related to physical discomfort like headache, earache, and teething pain.

The medicine is commonly used to help with symptoms related to systemic imbalance and discomfort related to inflammatory or irritative states. It is often applied during phases when symptoms become more noticeable, offering symptomatic relief that supports general well-being during symptomatic phases.


Quick Fact: Support for Acute Discomfort The medicine provides supportive relief when symptoms interfere with routine activities by addressing mild-to-moderate physical discomfort and assisting with maintaining functional stability during temporary episodes of fever and aches.


This supportive relief contributes to improved day-to-day comfort during symptomatic periods, and is relevant across acute therapeutic contexts involving pain, fever, and discomfort linked to minor swelling or inflammation.

Regulatory References

  1. Australian Therapeutic Goods Administration (TGA) monograph
Advertisements

Eligibility and Restrictions for Use

Eligibility for the use of Nurofen Children (Ibuprofen Oral Suspension) is strictly defined by regulatory agencies based on specific population rules. The medicine is officially allowed for the pediatric population aged 3 months and older who meet a minimum body weight of 5 kilograms. Use is not recommended for infants who are below this official age or weight threshold.

Eligibility Status Key Restriction/Population
Contraindicated Individuals with known hypersensitivity to Ibuprofen, Aspirin, or other NSAIDs, or a history of recurrent GI ulceration or bleeding linked to prior NSAID therapy.
Contraindicated Patients suffering from severe heart failure (NYHA Class IV), severe renal failure, or severe hepatic dysfunction. Use is also prohibited during the third trimester of pregnancy.
Conditional Use Caution is required for patients with mild-to-moderate renal or hepatic impairment, certain autoimmune conditions like Systemic Lupus Erythematosus, or conditions like Crohn's Disease.
Conditional Use Dehydrated children require specific clinical assessment before use due to regulatory warnings concerning the risk of renal impairment.
Lactation Status Use is generally considered compatible with short-term, low-dose administration as only trace amounts pass into breast milk.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Ibuprofen, the active ingredient in Nurofen Children, documents specific interaction patterns with other medicines and substances. These interactions are categorized based on their mechanism, affecting either the exposure (plasma concentration) or the intended effect of co-administered products.


Documented Interaction Patterns

Interaction Type Interacting Agents (Examples) Officially Documented Outcome
Pharmacodynamic Risk Enhancement Other NSAIDs and Anticoagulants (e.g., Warfarin) Increased risk of gastrointestinal bleeding or adverse effects. Co-administration with other NSAIDs is formally contraindicated.
Pharmacokinetic Exposure Modification Lithium, Digoxin, Methotrexate Increased plasma concentrations of the co-administered drug due to reduced clearance.
Pharmacodynamic Efficacy Reduction Antihypertensives (e.g., ACE Inhibitors), Diuretics Ibuprofen may reduce the documented therapeutic effects of these medicines.

Administration Constraints and Restrictions

Regulatory documents outline specific restrictions. Co-administration with other NSAIDs (including COX-2 inhibitors) is a formal restriction. For patients taking immediate-release low-dose Aspirin for cardioprotection, official timing constraints require Ibuprofen to be administered at least 8 hours before or 30 minutes after the Aspirin dose to prevent interference with its antiplatelet effect. Concomitant consumption of alcohol is documented to increase the risk of gastrointestinal bleeding.

Advertisements

Mechanism of Action

How Nurofen Children Works

The active substance, ibuprofen, is classified chemically as a propionic acid derivative and pharmacologically as a nonsteroidal anti-inflammatory drug (NSAID). Its primary mechanism of action involves the non-selective inhibition of the cyclooxygenase (COX) enzymes, specifically both the COX-1 and COX-2 isoforms. Ibuprofen reversibly binds to the active site of these enzymes, preventing the conversion of arachidonic acid into prostanoids.

This inhibition results in a substantial reduction in the biosynthesis of various prostanoids, including prostaglandins and thromboxanes, in peripheral tissues and the central nervous system. Prostaglandins are lipid compounds that function as key mediators in several physiological processes, including local inflammation and the central regulation of body temperature (pyresis). The resulting lower systemic concentration of these eicosanoids leads directly to a modulation of these cellular and system-level biochemical pathways.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Administration of Ibuprofen oral suspension is strictly defined by guidelines, which govern dose calculation, timing, and preparation to ensure proper use. The medicine is delivered via the oral route of administration as an oral suspension with a common concentration of 100 mg per 5 mL.

Dosing and Frequency

Official instructions establish that dosing is primarily determined by the child’s body weight in kilograms (kg), using age as a secondary factor. The standard regimen involves a single dose of 7 to 10 mg per kilogram of body weight. Administration is limited by a maximum total daily dose of 30 mg per kilogram of body weight in divided doses, which must not be exceeded.

To prevent overuse, doses must be separated by a minimum interval, typically ranging from 4 to 6 hours, and administration is limited to a maximum of three to four doses within any 24-hour period.

Preparation and Administration

For proper procedural administration, the oral suspension bottle must be shaken vigorously prior to each use. Crucially, only the enclosed dosing device (syringe or cup) should be used to measure the required volume in milliliters (mL) to ensure accurate delivery.

Use Context and Duration

Usage is exclusively intended for short-term administration. The medicine may be administered with or after food if the child has a sensitive stomach, or without reference to meals. The product is not intended for infants under 3 months of age or those weighing less than 5 kilograms. If the medicine is required for more than three days, official guidelines advise seeking medical consultation, reinforcing the short-term use pattern.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nurofen Children


Evidence for Use in Fever Reduction (Pyrexia)

A large body of Randomized Controlled Trials (RCTs) has been studied for the active ingredient in children experiencing fever, forming the basis of many systematic reviews. Researchers focused on outcomes related to systemic imbalance, such as measuring the change in body temperature and determining the time it takes for a child to return to a normal temperature. Studies also explored patient-reported experiences related to discomfort. The available data show patterns related to outcomes describing episodic or acute changes in body temperature in the studied pediatric populations during these short-term observation periods. While short-term changes are often described, the evidence provides limited insight into patterns associated with prolonged or repeated use for fever alone.


Evidence for Use in Acute Pain Relief (Analgesia)

Research exploring pain relief has centered on short-term RCTs that were structured to compare the substance's effect against inactive controls or alternative agents. These studies were applied in research contexts involving fluctuating or unstable symptoms of pain, such as outcomes related to physical discomfort from headaches, earaches, toothaches, and minor injuries. The studies monitored patient-reported outcomes describing perceived discomfort and tracked the need for additional medication. Findings help contextualize how patients reported their experience within short-term follow-up intervals. A key research limitation frame is the variability across studies in the specific pain scales and timing of measurements.


Research Scope and Limitations

The research structure for the anti-inflammatory role is based on the substance's pharmacological classification and its evaluation in trials for conditions linked to inflammatory states. Studies often explored anti-inflammatory outcomes as a secondary focus alongside core fever and pain measurements. The majority of the available, controlled research for both pain and fever is derived from studies with follow-up durations that were limited to the short term (24 to 48 hours). Research provides limited insight into long-term patterns of response. The active substance was evaluated in children from 6 months up to 12 years; however, evidence is limited for children with significant underlying health issues or for infants younger than six months, and results apply only to the populations studied.

Key Studies & References

  1. OTC medicine monograph: Ibuprofen for oral use - Therapeutic Goods Administration (TGA)
  2. 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Nurofen Children (FAQ)

Q: Is Nurofen Children safe to use for a child with asthma?

Official drug labeling often advises against using this medicine if a child has previously experienced asthma symptoms, hives, or an allergic reaction after taking ibuprofen, aspirin, or another NSAID. Regulatory warnings note that nonsteroidal anti-inflammatory drug (NSAID) use is associated with the exacerbation of asthma symptoms in sensitive individuals. For a child with asthma, regulatory guidance advises careful consideration prior to use.


Q: Can Nurofen Children interfere with antibiotics?

Official documents that list drug-drug interactions for ibuprofen do not formally list an interaction with common antibiotics, such as amoxicillin. General regulatory guidelines suggest discussing all concurrent medications with a healthcare provider, as NSAIDs can increase the risk of gastrointestinal adverse events, which is a common precaution.


Q: Can a child with a known heart condition use Nurofen Children?

Regulatory guidance strictly contraindicates the use of this medicine in patients who have severe heart failure (e.g., NYHA Class IV). For children with other heart conditions, official labeling indicates that careful medical consideration and use of the lowest effective amount for the shortest duration are necessary.


Q: Does the liquid form of Nurofen Children need to be refrigerated?

Official regulatory instructions for storage generally state that the medicine should be kept at a temperature not exceeding 25 C and protected from light. The official product information for the liquid suspension typically does not require refrigeration.


Q: Can children who are taking medications for ADHD use Nurofen Children?

Official regulatory resources do not generally list a formal interaction between ibuprofen and common medications used for ADHD. However, given the warnings regarding co-administered drugs and underlying health conditions, seeking guidance from a healthcare provider is generally recommended for all concurrent therapies.


Q: Does Nurofen Children cause drowsiness in children?

Drowsiness (somnolence), headache, and dizziness are sometimes listed among the possible nervous system adverse reactions in official regulatory documents for the active ingredient, ibuprofen. These are classified as uncommon or rare side effects that may occur during use.


Q: Why is it advised to use the lowest effective amount?

Regulatory documents advise using the lowest effective amount for the shortest duration necessary because the risk of serious adverse reactions, including gastrointestinal issues and cardiovascular events, is generally associated with higher doses and prolonged use.


Q: How quickly does Nurofen Children usually start working for fever?

Clinical data supporting the drug's use indicates that the maximum temperature reduction from a single dose typically occurs approximately 3 to 4 hours after the medicine is administered. The medicine is intended to provide temporary symptomatic relief.


Q: Why are there warnings about internal bleeding with this type of medicine?

Warnings are issued because ibuprofen is an NSAID that can disrupt the natural protective mechanisms of the stomach lining. This increases the risk of gastrointestinal inflammation, bleeding, ulceration, and perforation, which official labeling notes can occur at any time during use.


Q: Are there different Nurofen Children products for different age groups, and what are the distinctions?

Official regulatory documents recognize different formulations, such as 'Infants' and 'Children's' suspensions. These products are primarily distinguished by their concentration of ibuprofen, with the infants' formulation typically having a higher concentration to allow a smaller volume to be administered.


Q: Does taking Nurofen Children prevent fever from coming back?

Ibuprofen is designed to provide temporary symptomatic relief by reducing the current fever (antipyresis) for a period of several hours. Official evidence supports its use for alleviating existing symptoms, but it does not support a claim that it prevents a fever from recurring once its effects have diminished.


Q: Is the medicine less effective if the child has a high fever?

Clinical studies support the effectiveness of ibuprofen for fever reduction across a range of body temperatures. Official drug labels do not generally contain comparative data that suggests the medicine is less effective based on the initial severity of the fever.


Q: Can Nurofen Children be given to a child with a history of severe allergies?

The medicine is strictly contraindicated in children with a known history of hypersensitivity to the active ingredient (ibuprofen), aspirin, or other NSAIDs. This restriction is due to the risk of severe allergic reactions, such as anaphylaxis, as noted in official safety information.


Q: Are there different formulations (suspension vs. suppositories) and what is the difference?

Ibuprofen is available in different forms, including the oral suspension and rectal suppositories. The oral suspension is the common route, while the suppository may be used when the oral route is unavailable (e.g., due to vomiting). Regulatory documents note that the route of administration can affect the rate of absorption.


Q: What are the known interactions with herbal supplements?

While specific herbal products are not always formally listed in drug regulatory documents, general warnings advise caution with supplements that have blood-thinning effects or other properties that could increase the risk of adverse reactions when co-administered with NSAIDs.


Q: Can Nurofen Children affect sleep patterns?

Official regulatory documents list nervous system disorders like dizziness and headache as possible side effects. However, disturbance of sleep patterns (such as insomnia or excessive sleepiness) in children is not commonly or explicitly listed as a primary adverse reaction.


Q: Are there any long-term research findings about giving ibuprofen to children?

Regulatory research overviews generally note that the majority of clinical trials supporting the drug’s primary uses have limited follow-up durations (often 24 to 48 hours). This structure provides limited insight into patterns associated with prolonged or repeated use over long time periods.


Q: Is it true that Nurofen Children can mask serious symptoms?

As a medicine that reduces pain and fever, it functions by alleviating symptoms. Official guidance advises users to seek medical attention if symptoms persist or worsen after short-term use, as the temporary reduction of fever and pain may potentially mask the signs of a serious underlying condition.


Q: What evidence exists regarding Nurofen Children's use in babies under 3 months?

Regulatory guidance states the product is not intended for infants under 3 months of age or those weighing less than 5 kilograms. This restriction is due to limited clinical evidence in this very young age group and regulatory concerns over immature renal function.


Q: Why might a child be vomiting after taking Nurofen Children?

Vomiting is listed in official documents as a possible adverse reaction, usually categorized under Gastrointestinal Disorders. This reaction is linked to the drug's known ability to cause irritation to the gastrointestinal tract.


Q: Is it okay if my child eats right after taking Nurofen Children?

Official administration instructions state that the medicine may be administered with or after food if the child has a sensitive stomach, or without reference to meals. Official instructions indicate that administration with or after food may help reduce the possibility of stomach irritation.


Q: Why is Nurofen Children often flavored (like strawberry or orange)?

The inclusion of flavoring agents is described in regulatory composition documents as a key feature for paediatric preparations. It is intended to enhance the medicine's palatability and facilitate the ease of administration for infants and young children who may have difficulty swallowing the medicine.


Q: Are there specific instructions for disposing of unused Nurofen Children?

Official regulatory guidance states that unused or expired medicine must not be thrown away via waste water or household refuse. Specific instructions often advise mixing the drug with an undesirable substance (like coffee grounds or dirt) and placing it in a sealed container before disposal, or using an official drug take-back program.

Advertisements

How should Nurofen Children be stored and disposed of?

Storage and Disposal of Nurofen for Children Oral Suspension

Official regulatory documents define specific storage and disposal requirements for this Ibuprofen oral suspension.

Storage Conditions

Requirement Official Instruction
Temperature Do not store above 25, C.
Protection Must be kept well closed and protected from light.
Container Store in the original container.
Stability Shelf life after opening is 6 months.
Safety Must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired medicine must not be thrown away via waste water or household refuse. Patients are instructed to ask a pharmacist how to properly dispose of the product, as these measures help to protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nurofen Children found in:

A-Z Index: